FDA Advisory Committee Recommended Approval of First Gene Therapy For Inherited Eye Disease

Tuesday, November 7, 2017

Foundation Fighting Blindness Chief Research Officer, Dr. Stephen Rose, discussed the FDA advisory panel recommended approval of Spark Therapeutics’ Gene Therapy Luxturna with MedicalResearch.com. Read the full interview on MedicalResearch.com here.